Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Dudley

Showing results (241-250 of 260) with videos related to

Pageof 26
Sort By:
Journal of Aging and Physical Activity|January 17, 2015
Innovative Research Design Exploring the Effects of Physical Activity and Genetics on Cognitive Performance in Community-Based Older AdultsJennifer L Etnier, Jeffrey D Labban, William B Karper, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 8, 2016
A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patientsPatrick A Flume, Donald R VanDevanter, Elizabeth E Morgan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 17, 2015
A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patientsJ Stuart Elborn, David E Geller, Douglas Conrad, et al.
Neurology|August 17, 2016
Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trialsPamela L Wolters, Staci Martin, Vanessa L Merker, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2003
Conformationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosaThomas E Renau, Roger Léger, Lubov Filonova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2022
Associations of Symptom Clusters and Health Outcomes in Adult Survivors of Childhood Cancer: A Report From the St Jude Lifetime Cohort StudyHyewon Shin, William N Dudley, Nickhill Bhakta, et al.
Clinical Endocrinology|February 21, 2006
Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumoursK J Bradley, B M Cavaco, M R Bowl, et al.
Journal of Oncology Practice|February 1, 2019
Evaluating the Impact of Treatment Care Planning on Quality MeasuresGabrielle B Rocque, Courtney P Williams, Amanda R Hathaway, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2004
Quinazolinone fungal efflux pump inhibitors. Part 2: In vitro structure-activity relationships of (N-methyl-piperazinyl)-containing derivativesWilliam J Watkins, Rémy C Lemoine, Lee Chong, et al.
HGG Advances|January 20, 2022
Orofacial overgrowth with peripheral nerve enlargement and perineuriomatous pseudo-onion bulb proliferations is part of the <i>PIK3CA</i>-related overgrowth spectrumIoannis G Koutlas, Ana-Lia Anbinder, Rana Alshagroud, et al.
Pageof 26

Showing results (241-250 of 260) with videos related to

Sort By:
Pageof 26
Journal of Aging and Physical Activity|January 17, 2015
Innovative Research Design Exploring the Effects of Physical Activity and Genetics on Cognitive Performance in Community-Based Older AdultsJennifer L Etnier, Jeffrey D Labban, William B Karper, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 8, 2016
A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patientsPatrick A Flume, Donald R VanDevanter, Elizabeth E Morgan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 17, 2015
A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patientsJ Stuart Elborn, David E Geller, Douglas Conrad, et al.
Neurology|August 17, 2016
Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trialsPamela L Wolters, Staci Martin, Vanessa L Merker, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2003
Conformationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosaThomas E Renau, Roger Léger, Lubov Filonova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2022
Associations of Symptom Clusters and Health Outcomes in Adult Survivors of Childhood Cancer: A Report From the St Jude Lifetime Cohort StudyHyewon Shin, William N Dudley, Nickhill Bhakta, et al.
Clinical Endocrinology|February 21, 2006
Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumoursK J Bradley, B M Cavaco, M R Bowl, et al.
Journal of Oncology Practice|February 1, 2019
Evaluating the Impact of Treatment Care Planning on Quality MeasuresGabrielle B Rocque, Courtney P Williams, Amanda R Hathaway, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2004
Quinazolinone fungal efflux pump inhibitors. Part 2: In vitro structure-activity relationships of (N-methyl-piperazinyl)-containing derivativesWilliam J Watkins, Rémy C Lemoine, Lee Chong, et al.
HGG Advances|January 20, 2022
Orofacial overgrowth with peripheral nerve enlargement and perineuriomatous pseudo-onion bulb proliferations is part of the <i>PIK3CA</i>-related overgrowth spectrumIoannis G Koutlas, Ana-Lia Anbinder, Rana Alshagroud, et al.
Pageof 26